1832 Asset Management L.P. Acquires 145,139 Shares of Becton, Dickinson and Company (NYSE:BDX)

1832 Asset Management L.P. raised its holdings in Becton, Dickinson and Company (NYSE:BDX) by 361.7% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 185,267 shares of the medical instruments supplier’s stock after acquiring an additional 145,139 shares during the quarter. 1832 Asset Management L.P. owned about 0.06% of Becton, Dickinson and Company worth $43,299,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in BDX. Vanguard Group Inc. boosted its holdings in Becton, Dickinson and Company by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 26,123,450 shares of the medical instruments supplier’s stock worth $6,369,681,000 after purchasing an additional 195,931 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its position in shares of Becton, Dickinson and Company by 1.8% in the second quarter. Massachusetts Financial Services Co. MA now owns 4,905,114 shares of the medical instruments supplier’s stock worth $1,146,374,000 after buying an additional 87,230 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Becton, Dickinson and Company by 8.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 4,412,163 shares of the medical instruments supplier’s stock worth $1,031,167,000 after acquiring an additional 346,720 shares in the last quarter. First Eagle Investment Management LLC increased its holdings in shares of Becton, Dickinson and Company by 32.5% during the 2nd quarter. First Eagle Investment Management LLC now owns 2,803,255 shares of the medical instruments supplier’s stock valued at $655,149,000 after acquiring an additional 688,296 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in shares of Becton, Dickinson and Company by 4.3% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,539,663 shares of the medical instruments supplier’s stock valued at $628,440,000 after acquiring an additional 105,821 shares in the last quarter. 86.97% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have issued reports on BDX. Raymond James decreased their target price on Becton, Dickinson and Company from $275.00 to $270.00 and set an “outperform” rating for the company in a research report on Friday, August 2nd. The Goldman Sachs Group initiated coverage on shares of Becton, Dickinson and Company in a research note on Thursday, May 30th. They issued a “buy” rating and a $274.00 target price on the stock. Evercore ISI cut their target price on shares of Becton, Dickinson and Company from $290.00 to $285.00 and set an “outperform” rating for the company in a research report on Tuesday, July 2nd. StockNews.com upgraded shares of Becton, Dickinson and Company from a “hold” rating to a “buy” rating in a report on Thursday, August 8th. Finally, Stifel Nicolaus lifted their price objective on Becton, Dickinson and Company from $270.00 to $280.00 and gave the stock a “buy” rating in a research note on Friday, July 26th. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $279.50.

Becton, Dickinson and Company Stock Down 0.5 %

NYSE BDX opened at $233.50 on Monday. Becton, Dickinson and Company has a twelve month low of $218.75 and a twelve month high of $269.52. The stock has a market cap of $67.48 billion, a PE ratio of 51.43, a PEG ratio of 1.91 and a beta of 0.42. The firm has a 50-day simple moving average of $235.51 and a 200 day simple moving average of $235.54. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.36 and a current ratio of 1.85.

Becton, Dickinson and Company (NYSE:BDX) last announced its quarterly earnings data on Thursday, August 1st. The medical instruments supplier reported $3.50 EPS for the quarter, topping analysts’ consensus estimates of $3.31 by $0.19. Becton, Dickinson and Company had a return on equity of 14.49% and a net margin of 7.13%. The company had revenue of $4.99 billion during the quarter, compared to the consensus estimate of $5.08 billion. During the same quarter last year, the company earned $2.96 EPS. The company’s quarterly revenue was up 2.3% on a year-over-year basis. On average, research analysts forecast that Becton, Dickinson and Company will post 13.1 EPS for the current year.

Becton, Dickinson and Company Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 9th will be paid a dividend of $0.95 per share. The ex-dividend date is Monday, September 9th. This represents a $3.80 dividend on an annualized basis and a yield of 1.63%. Becton, Dickinson and Company’s dividend payout ratio is currently 83.70%.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.